Work

HOG pathway modulation is a determinant of echinocandin treatment failure in Candidozyma auris

Year: 2026
Type: preprint
Abstract: Candidozyma auris is a rapidly emerging fungal pathogen whose drug-resistant profile poses a formidable challenge to antifungal treatment. Echinocandins are the recommended first-line therapy for invasive C. auris infections, but resistance to this drug class is on the rise. Here we show that, beyond resistance, C. auris can readily acquire genetically encoded echinocandin tolerance, a phenotype of slow but sustained growth and increased survival at concentrations above the minimum inhibitory concentration (MIC) that reflects incomplete maximal inhibition and a reduced Hill coefficient without an increase in MIC. Tolerance was therefore undetectable by standard clinical susceptibility testing, yet it significantly reduced treatment efficacy in an immunocompromised murine model of systemic infection. Genetic dissection revealed that tolerance arises through disruption of the high-osmolarity glycerol (HOG) mitogen-activated protein kinase (MAPK) pathway through the loss of function of Ssk1, Ssk2, Pbs2 or Hog1, or specific substitutions in Nik1. The disruption of the HOG pathway did not confer fitness or virulence defects in C. auris, and in Candida albicans and Nakaseomyces glabratus, it did not confer tolerance, suggesting a unique non-essential rewiring of this pathway in C. auris. Proteomic and cell-wall analyses linked tolerance to altered cell-wall remodelling during echinocandin exposure. Evolutionary modelling and deep sequencing of FKS1 hotspots in experimentally evolved populations showed that tolerance increases the rate at which resistance-conferring FKS1 hotspot substitutions emerge. Putative high-impact mutations in HOG pathway effectors in clinical isolates suggest that this phenotype occurs in patients, where it might reduce treatment efficacy or facilitate resistance emergence. This work therefore identifies HOG-mediated acquired tolerance as a hidden clinically relevant direct and indirect determinant of echinocandin treatment failure.
Language: English
Field: Medicine
Open Access status: green
Awards: G1011636513, G1082060630, G1276714150, G1356439345, G1620553015, G1736529879, G1855990336, Exploring evolution dynamics in multidrug resistant Candida species: a focus on fitness-resistance associations and collateral sensitivity, Medical Research Council Centre for Medical Mycology Studentships, MRC Centre in Medical Mycology Studentships, G252646220, MRC Centre for Medical Mycology, PersiSTRESS: How the stress-resistance antiporter GadC integrates bacterial osmoregulation and pH homeostasis with antibiotic-tolerant persistence, G3697191423, G3865836533, Optimization and validation of collateral sensitivity based alternative treatment strategies for multidrug resistant Candidemia, G410571670, G430777504, G451917667, G4612402534, G4887036848, Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance, G4977656371, Mechanistic insights into fungal pathogenicity and drug resistance using a novel lineage of Cryptococcus, G523076202, IMPACT OF FUNGAL ADAPTATION UPON HOST RECOGNITION AND PATHOGENESIS, Unraveling the multidrug resistance, drug tolerance, and collateral sensitivity in the emergent nosocomial fungus C. auris using experimental evolution and multi-omics analysis., G5421974903, G5967599077, G7000784184, G7262464314, G7955648117, Genetic and chemical validation of sugar nucleotide biosynthesis as a target against Candida albicans, Comparative analysis of resistance-fitness evolution in multidrug resistant Candida species: a role for fitness trade-off compensation and hypermutators?, G8915940379, G9001340451, G9001347507, G99296377
OpenAlex ID: W7234346919
Cites: 79
Cited by:
Related to: 10